Subscribe to our newsletter.
Copyright 2025 © All rights Reserved Goffin Molecular Technologies
X
- No products in the list
Precision in Every Drop: Unpacking the Liquid Biopsy OncoKit
The Liquid Biopsy OncoKit is a specialized tool for lung cancer diagnosis and monitoring. Using just 10 ng of ctDNA, it employs Next-Generation Sequencing to identify key mutations for personalized treatment. The kit offers a broad diagnostic scope, including multi-gene sequencing, hotspot detection, and fusion gene capture.
In-Depth Analysis, One Drop at a Time: The Liquid Biopsy OncoKit Explained
The Liquid Biopsy OncoKit is engineered specifically for patients affected by lung cancer. Utilizing cutting-edge Next-Generation Sequencing (NGS), the kit is capable of detecting key mutations that are predictive of response to treatment. This enables highly personalized treatment plans and allows for early detection of resistance and relapse.
The beauty of Liquid Biopsy OncoKit lies in its ability to conduct a single test using just a minimal 10 ng of ctDNA, offering a comprehensive snapshot that is crucial for targeted therapy. It can detect mutations that may emerge as resistance mechanisms or through clonal evolution, making it invaluable both for initial diagnosis and monitoring treatment outcomes.
Integrated Features for Comprehensive Analysis
Multi-Gene Sequencing
The kit sequences entire exonic regions of 13 critical genes: ALK, BRAF, EGFR, ERBB2/Her2, KIT, KRAS, MAP2K1, MET, NRAS, PIK3CA, RB1, ROS1, TP53
Hotspot Regions
It also targets hotspot regions of NTRK1 and NTRK3 to further broaden the spectrum of actionable mutations.
Fusion Gene Capture
For fusion gene identification, all possible rearrangements are covered: ALK (introns 18 and 19), EGFR (introns 24, 25, and 26), ETV6-NTRK3 (introns 4 and 5), NRG1 (introns 1, 4, and 5), NTRK1 (introns 9, 10, 11, 12, and 13), NTRK2 (intron 15), RET (introns 9, 10, and 11) and ROS1 (introns 31, 32, 33, 34, and 35).
Copy Number Variations (CNVs)
Our kit goes beyond mutations and rearrangements. It also detects CNVs across the genome, thanks to a sophisticated low-density SNP array.
The Last Word: How the Liquid Biopsy OncoKit is Changing the Standard of Care
With the Liquid Biopsy OncoKit, we’re not just offering a product; we’re offering a paradigm shift in the way cancer is diagnosed and treated. Our kit combines efficiency, precision, and a comprehensive approach, setting a new benchmark in cancer diagnostics. Isn’t it time you brought this revolutionary technology into your laboratory?
For a future where every second counts, choose precision. Choose the Liquid Biopsy OncoKit.
The kit is equipped with reagents for 24 reactions, including:
Instructions for Use
MSDS Liquid Biopsy OncoKit
For any missing information or if you require additional details, please do not hesitate to contact us.
Subscribe to our newsletter.